Pfizer's Prevenar 13 receives European approval to include adults for...
Pfizer Inc. announced today the company's pneumococcal conjugate vaccine, Prevenar 13 (pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]), received European approval for an expanded...
View ArticleInfant vaccination against pneumonia helps protect elderly
Children who receive a vaccine to prevent blood and ear infections, appear to be reducing the spread of pneumonia to the rest of the population, especially their grandparents and other older adults.
View ArticleEuropean Commission approves updated label of Prevenar 13 for high risk...
Pfizer Inc. (NYSE:PFE) announced today that the European Commission approved updates to the Summary of Product Characteristics (SmPC) for the company's pneumococcal conjugate vaccine Prevenar 13*...
View ArticleGenocea commences GEN-004 Phase 1 study to prevent pneumococcus infections
Genocea Biosciences, Inc., a clinical-stage company pioneering novel T cell vaccines, announced today that it has initiated a Phase 1 study of GEN-004, an investigational vaccine candidate for...
View ArticleAstellas, ClearPath announce strategic partnership to develop vaccine for...
Astellas Pharma Inc. (Astellas) and ClearPath Development Company (ClearPath) announced today a strategic partnership to form a portfolio of development companies focused on vaccines targeting...
View ArticlePrevalence of bacterial meningitis drops in the United States
Advances in the prevention and treatment of an often fatal condition called bacterial meningitis appear to be paying dividends in the United States, report infectious disease experts at The University...
View ArticleMedical advisory panel recommends new pneumonia vaccine for seniors
The experts expressed concern, however, that Medicare rules may hamper some people from getting the new vaccine if they have already had an older version. Also in drug issues, some patient advocates...
View ArticleImportant vaccines that should not be missed by adults, elders and pregnant...
Vaccines are an important part of routine healthcare for adults, seniors and women who are pregnant.
View ArticleOne-shot vaccine passes key preclinical test in newborn monkey models
Newborns are highly vulnerable to infections and don't respond optimally to most vaccines because their young immune systems typically mount weak antibody responses.
View ArticleNew vaccine for pneumonia holds promise to save thousands of lives
In 2004, pneumonia killed more than 2 million children worldwide, according to the World Health Organization. By 2015, the number was less than 1 million.
View ArticleThe ratcheting cost of the pneumococcal vaccine: What gives?
Every November, like clockwork, she gets the same letter, said Dr. Lindsay Irvin, a pediatrician in San Antonio.
View ArticleRecommending adults to get pneumococcal vaccine at age 50 may be effective...
If mitigating racial disparities in those who contract pneumococcal diseases, such as meningitis and pneumonia, is a top public health priority, then recommending that all adults get a pneumococcal...
View ArticleVaccine reduces race-based pneumococcal disease disparities
In a major public health success, the introduction of pneumococcal conjugate vaccine PCV13, or Prevnar 13, in 2010 in the United States is associated with reduction in socioeconomic disparities and the...
View ArticleTime to discuss potentially unpleasant side effects of COVID shots?...
Drugmaker Pfizer is expected to seek federal permission to release its COVID-19 vaccine by the end of November, a move that holds promise for quelling the pandemic, but also sets up a tight time frame...
View ArticleNew technology can provide immunization against infectious diseases
A single-use, self-administered microneedle technology developed by UConn faculty to provide immunization against infectious diseases has recently been validated by preclinical research trials.
View Article